{
    "id": "b623b8b8-5503-4354-9bfd-4610257ceb87",
    "code": {
        "code": "34391-3",
        "codeSystem": "2.16.840.1.113883.6.1",
        "displayName": "HUMAN PRESCRIPTION DRUG LABEL"
    },
    "organization": "Seton Pharmaceuticals",
    "effectiveTime": "20250312",
    "ingredients": [
        {
            "name": "FOLIC ACID",
            "code": "935E97BOY8",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_37527"
        },
        {
            "name": ".BETA.-CAROTENE",
            "code": "01YAE03M7J",
            "chebi_id": null,
            "drugbank_id": "DB06755"
        },
        {
            "name": "CALCIUM ASCORBATE",
            "code": "183E4W213W",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_22651"
        },
        {
            "name": "CHOLECALCIFEROL",
            "code": "1C6V77QF41",
            "chebi_id": null,
            "drugbank_id": "DB00169"
        },
        {
            "name": ".ALPHA.-TOCOPHEROL ACETATE, DL-",
            "code": "WR1WPI7EW8",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_30089"
        },
        {
            "name": "THIAMINE MONONITRATE",
            "code": "8K0I04919X",
            "chebi_id": null,
            "drugbank_id": "DB00152"
        },
        {
            "name": "RIBOFLAVIN",
            "code": "TLM2976OFR",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_17015"
        },
        {
            "name": "NIACINAMIDE",
            "code": "25X51I8RD4",
            "chebi_id": null,
            "drugbank_id": "DB00627"
        },
        {
            "name": "PYRIDOXINE HYDROCHLORIDE",
            "code": "68Y4CF58BV",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_16709"
        },
        {
            "name": "CYANOCOBALAMIN",
            "code": "P6YC3EG204",
            "chebi_id": null,
            "drugbank_id": "DB00115"
        },
        {
            "name": "CALCIUM PANTOTHENATE",
            "code": "568ET80C3D",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_16454"
        },
        {
            "name": "CALCIUM CARBONATE",
            "code": "H0G9379FGK",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_41609"
        },
        {
            "name": "FERROUS FUMARATE",
            "code": "R5L488RY0Q",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_31607"
        },
        {
            "name": "ZINC OXIDE",
            "code": "SOI2LOH54Z",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_25741"
        },
        {
            "name": "ACACIA",
            "code": "5C5403N26O",
            "chebi_id": null,
            "drugbank_id": "DB10451"
        },
        {
            "name": "SILICON DIOXIDE",
            "code": "ETJ7Z6XBU4",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_30563"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30",
            "chebi_id": null,
            "drugbank_id": "DB14077"
        },
        {
            "name": "ORANGE JUICE",
            "code": "5A9KE2L9L3",
            "chebi_id": null,
            "drugbank_id": "DB10549"
        },
        {
            "name": "STEARIC ACID",
            "code": "4ELV7Z65AP",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_37527"
        },
        {
            "name": "STEVIA REBAUDIUNA LEAF",
            "code": "6TC6NN0876",
            "chebi_id": null
        },
        {
            "name": "SUCROSE",
            "code": "C151H8M554",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_17992"
        }
    ],
    "indications": [
        {
            "text": "usage se-natal 19 chewable tablets indicated improving nutritional status women throughout pregnancy postnatal period lactating non-lactating mothers . se-natal 19 chewable tablets also useful improving nutritional status women prior conception .",
            "doid_id": null,
            "orphanet_id": null
        }
    ],
    "contraindications": [
        {
            "text": "product contraindicated patients known hypersensitivity ingredients .",
            "doid_id": "http://purl.obolibrary.org/obo/DOID_1205",
            "orphanet_id": null
        }
    ],
    "warningsAndPrecautions": "folic acid alone improper therapy treatment pernicious anemia megaloblastic anemias vitamin b 12 deficient . warning : accidental overdose iron-containing products leading cause fatal poisoning children 6. keep product reach children . case accidental overdose , call doctor poison control center immediately.precautions general take 2 hours meals . exceed recommended dose . discontinue symptoms intolerance appear . \u200bfolic acid folic acid doses 0.1 mg daily may obscure pernicious anemia . hematologic remission occur neurological manifestations remain progressive . \u200bpediatric safety effectiveness pediatric patients established . \u200bgeriatric dosing elderly patients cautious . due greater frequency decreased hepatic , renal , cardiac function , concomitant disease therapy , dosing start lower end dosing range .",
    "adverseReactions": "\u200badverse iron therapy may include gi irritation , constipation , diarrhea , nausea , vomiting , dark stools . iron therapy usually transient . allergic sensitization reported following oral parenteral folic acid .",
    "indications_original": "INDICATIONS AND USAGE Se-Natal 19 Chewable Tablets are indicated for use in improving the nutritional status of women throughout pregnancy and in the postnatal period for both lactating and non-lactating mothers. Se-Natal 19 Chewable Tablets are also useful in improving the nutritional status of women prior to conception.",
    "contraindications_original": "CONTRAINDICATIONS This product is contraindicated in patients with a known hypersensitivity to any of the ingredients.",
    "warningsAndPrecautions_original": "WARNINGS Folic acid alone is improper therapy in the treatment of pernicious anemia and other megaloblastic anemias where vitamin B 12 is deficient. WARNING: Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under 6. Keep this product out of reach of children. In case of accidental overdose, call a doctor or poison control center immediately.PRECAUTIONS GENERAL Take 2 hours after meals. Do not exceed recommended dose. Discontinue use if symptoms of intolerance appear. \u200bFolic Acid Folic acid in doses above 0.1 mg daily may obscure pernicious anemia. In that hematologic remission can occur while neurological manifestations remain progressive. \u200bPediatric Use Safety and effectiveness in pediatric patients have not been established. \u200bGeriatric Use Dosing for elderly patients should be cautious. Due to the greater frequency of decreased hepatic, renal, or cardiac function, and of concomitant disease or other drug therapy, dosing should start at the lower end of the dosing range.",
    "adverseReactions_original": "\u200bADVERSE REACTIONS Adverse reactions with iron therapy may include GI irritation, constipation, diarrhea, nausea, vomiting, and dark stools. Adverse reactions with iron therapy are usually transient. Allergic sensitization has been reported following both oral and parenteral administration of folic acid.",
    "drug": [
        {
            "name": "FOLIC ACID",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_37527"
        }
    ]
}